Sign in

Private company

Foundation Medicine

Logo: Foundation Medicine, Public domain, via Wikimedia Commons3

American genomics company

Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2010Founded1

See how the biggest companies compare on our leaderboards

Foundation Medicine (54960820108)
Photo: ajay_suresh, CC BY 4.0, via Wikimedia Commons4

Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.2

Timeline

  1. 2010Founded Founded1

Calendar

Drug trials and FDA: recently

  1. Oct 22, 2024Phase 4 trial completed Phase 4 trial of olaparib, enzalutamide and others in Metastatic Castration-resistant Prostate Cancer, run by AstraZeneca: primary completion Oct 22, 2024, results posted Dec 19, 2025 (ClinicalTrials.gov NCT05457257).5

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$180.0M 2014–2026
Money received by yearMoney received by year, 2014–2026: $180.0M in all. Federal contracts $180.0M.$0$10M$20M$30M$40M2014 · Federal contracts: $16.2K20142015 · Federal contracts: $46.8K20162017 · Federal contracts: $21.1K2018 · Federal contracts: $23.1K20182019 · Federal contracts: $29.2M2020 · Federal contracts: $15.6M20202021 · Federal contracts: $12.3M2022 · Federal contracts: $35.0M20222023 · Federal contracts: $9.2M2024 · Federal contracts: $27.9M20242025 · Federal contracts: $28.5M2026 · Federal contracts: $22.3M2026
Figures by year
YearFederal contractsTotal
2026$22.3M$22.3M
2025$28.5M$28.5M
2024$27.9M$27.9M
2023$9.2M$9.2M
2022$35.0M$35.0M
2021$12.3M$12.3M
2020$15.6M$15.6M
2019$29.2M$29.2M
2018$23.1K$23.1K
2017$21.1K$21.1K
2015$46.8K$46.8K
2014$16.2K$16.2K

Federal awards

Obligated amounts from USAspending.gov6, by calendar year, 2014–2026, for its registration. Obligations are what agencies committed, not always what was paid out. Contracts pay for goods and services; grants, loans and direct payments are assistance. Loans are charted at the face value of the loans listed here. An award’s amount below is its lifetime total, and some began before the years charted.

Largest contracts

  1. Oct 2, 2024$24.0M from Department of Veterans Affairs: Task order for base year7 To FOUNDATION MEDICINE, INC. Award 36C10G25F0005
  2. Oct 1, 2021$22.4M from Department of Veterans Affairs: Genomic sequencing testing services8 To FOUNDATION MEDICINE, INC. Award 36C10G22N0002
  3. Oct 3, 2023$22.4M from Department of Veterans Affairs: Genomic sequencing testing services9 To FOUNDATION MEDICINE, INC. Award 36C10G24N0009
  4. Oct 1, 2020$22.2M from Department of Veterans Affairs: Genomic sequencing testing services10 To FOUNDATION MEDICINE, INC. Award 36C10G21N0002

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10